# Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

> **NCT05892432** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 50 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Semaglutide 3 MG [Rybelsus]
- **DRUG:** Semaglutide 7 MG [Rybelsus]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05892432
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-11
- **Primary completion:** 2025-11-04
- **Final completion:** 2025-11-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892432, "Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05892432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*